FDA's Compounding Advisory Committee's Effects for Compounding Pharmacists

Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA's Compounding Advisory Committee will affect the daily practice of compounding pharmacists.

Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA’s Compounding Advisory Committee will affect the daily practice of compounding pharmacists.

This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.